These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16082989)

  • 21. A role for the micro-organism in the outcome from infection? A principle challenged.
    Cohen J
    Crit Care Med; 2011 Aug; 39(8):2001-2. PubMed ID: 21768806
    [No Abstract]   [Full Text] [Related]  

  • 22. New antibiotics for severe ICU-aquired bacterial infections.
    Poissy J; Senneville E
    Infect Disord Drug Targets; 2011 Aug; 11(4):401-12. PubMed ID: 21679140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
    Rhomberg PR; Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2006 Sep; 56(1):57-62. PubMed ID: 16631338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bacteriologic profile and antibiogram of blood culture isolates from a children's hospital in Kabul.
    Tariq TM
    J Coll Physicians Surg Pak; 2014 Jun; 24(6):396-399. PubMed ID: 24953929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock.
    Vazquez-Guillamet C; Scolari M; Zilberberg MD; Shorr AF; Micek ST; Kollef M
    Crit Care Med; 2014 Nov; 42(11):2342-9. PubMed ID: 25072764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Joseph J; Rodvold KA
    Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of carbapenems in the treatment of serious infections.
    Baughman RP
    J Intensive Care Med; 2009; 24(4):230-41. PubMed ID: 19617229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Empiric Antibiotic Therapy of Nosocomial Bacterial Infections.
    Reddy P
    Am J Ther; 2016; 23(4):e982-94. PubMed ID: 24413366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Distribution of pathogen and resistance of nosocomial infections in the intensive care units].
    Dai CM; Zhou JD; Wu Y; Qi Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):277-80. PubMed ID: 16706133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit.
    Bennett KM; Scarborough JE; Sharpe M; Dodds-Ashley E; Kaye KS; Hayward TZ; Vaslef SN
    J Trauma; 2007 Aug; 63(2):307-11. PubMed ID: 17693828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doripenem: position in clinical practice.
    Dedhia HV; McKnight R
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):507-14. PubMed ID: 19485791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Emergence pathogens infections in ENT Department of Children's hospital in 2005-2008].
    Zielnik-Jurkiewicz B; Rakowska-Szkudlarek M
    Otolaryngol Pol; 2009; 63(6):513-9. PubMed ID: 20198987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Distribution and drug resistance profiles of pathogenic bacteria isolated from patients with nosocomial infection in intensive care unit].
    Qin Y; Chen X; Huang D; Wei L
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Oct; 32(10):1513-5. PubMed ID: 23076198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long term care units--nest of resistant bacteria?].
    Laine J; Lumio J
    Duodecim; 2005; 121(15):1679-81. PubMed ID: 16211842
    [No Abstract]   [Full Text] [Related]  

  • 36. Surveillance of multidrug resistant organisms in tertiary care hospital in Delhi, India.
    Wattal C; Goel N; Oberoi JK; Raveendran R; Datta S; Prasad KJ
    J Assoc Physicians India; 2010 Dec; 58 Suppl():32-6. PubMed ID: 21563611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial organisms and antimicrobial resistance patterns.
    Varghese GK; Mukhopadhya C; Bairy I; Vandana KE; Varma M
    J Assoc Physicians India; 2010 Dec; 58 Suppl():23-4. PubMed ID: 21563609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and antimicrobial resistance among commonly encountered bacteria associated with infections and colonization in intensive care units in a university-affiliated hospital in Shanghai.
    Tan R; Liu J; Li M; Huang J; Sun J; Qu H
    J Microbiol Immunol Infect; 2014 Apr; 47(2):87-94. PubMed ID: 23357606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study.
    Kiratisin P; Chongthaleong A; Tan TY; Lagamayo E; Roberts S; Garcia J; Davies T
    Int J Antimicrob Agents; 2012 Apr; 39(4):311-6. PubMed ID: 22386743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.